RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

GlaxoSmithKline PLC

A collection of news and information related to GlaxoSmithKline PLC published by this site and its partners.

Top GlaxoSmithKline PLC Articles

Displaying items 89-99
  • Drug companies pay $25 million to Illinois doctors

    Drug companies pay $25 million to Illinois doctors
    At least three dozen doctors in Illinois received payments and perks exceeding $100,000 from drug companies between 2009 and early 2011, according to an updated database that now includes information from a dozen pharmaceutical firms. Doctors in the...
  • Asthma drugs may increase attacks in kids: report

    Asthma drugs may increase attacks in kids: report
    NEW YORK (Reuters Health) - One class of drugs used to prevent wheezing and shortness of breath in people with asthma may increase kids' risk of being hospitalized for an asthma attack, according to a new analysis from the U.S. Food and Drug...
  • IUDs almost halve risk of cervical cancer: study

    IUDs almost halve risk of cervical cancer: study
    LONDON (Reuters) - Contrary to popular belief, intrauterine contraceptive devices might actually protect women against developing cervical cancer even though they don't stop the infection that commonly leads to the disease, according to the results of...
  • Dangerous pharmaceuticals marketed as supplements

    Dangerous pharmaceuticals marketed as supplements
    Shengyang Zhou assured the American buyers that his Chinese-made weight-loss capsules were safe. Zhou was sure because he had a test — one person eats a whole bottle. Such a person would have "maybe some stomach problem, but not die," he told...
  • EU advises all girls need cervical cancer vaccines

    EU advises all girls need cervical cancer vaccines
    LONDON (Reuters) - All girls in Europe should be immunized against the human papillomavirus (HPV) that causes cervical cancer and current vaccine coverage rates are far too low, European Union health officials said on Wednesday. In new advice about...
  • Human Genome Sciences announces plan to lay off 114

    Rockville-based Human Genome Sciences has warned state regulators that it plans to cut 114 jobs beginning in October, three months after striking a deal to be acquired by GlaxoSmithKline. Human Genome, which employs about 1,000 people in Rockville, could...
  • Human Genome to lay off 97 workers

    Human Genome Sciences Inc., which was acquired for $3.6 billion by London-based GlaxoSmithKline Plc in August, intends to lay off 97 employees in mid-December, and an additional but unspecified number of cuts are planned for next year, the company...
  • Ripley's opens Odditorium at Harborplace

    Ripley's Believe It or Not, one of the first of several new tenants opening for the summer tourist season at Harborplace in downtown Baltimore, will open Saturday in the Light Street Pavilion. Ripley Entertainment Inc. said exhibits at the Inner Harbor...
  • Pennsylvania to receive more than $13 million as part of GlaxoSmithKline healthcare fraud settlement

    Pennsylvania to receive more than $13 million as part of GlaxoSmithKline healthcare fraud settlement
    Attorney General Linda Kelly today announced that Pennsylvania will receive more than $13 million as part of the largest healthcare fraud settlement in United States history. Kelly said that GlaxoSmithKline, a British based pharmaceutical company that...
  • GlaxoSmithKline to pay $3 billion healthcare fraud settlement, U.S. says

    GlaxoSmithKline to pay $3 billion healthcare fraud settlement, U.S. says
    Pharmaceutical drug maker GlaxoSmithKline will pay $3 billion and plead guilty to federal charges to resolve a slew of criminal and civil issues stemming from its use of kickbacks, mis-branding and other misconduct to market drugs such as Paxil,...
  • Report: Dr. Drew Paid $275K to Promote Antidepressant

    Report: Dr. Drew Paid $275K to Promote Antidepressant
    LOS ANGELES (KTLA) -- Celebrity addiction specialist Dr. Drew Pinsky is under fire for helping market an antidepressant for uses not approved by the Food and Drug Administration. GlaxoSmithKline, which makes the drug Wellbutrin, agreed to pay a $3...